BEAM – beam therapeutics inc. (US:NASDAQ)
Stock Stats
News
Beam Therapeutics (BEAM) had its price target raised by Royal Bank Of Canada from $22.00 to $26.00. They now have a "sector perform" rating on the stock.
Beam Therapeutics (BEAM) had its price target raised by Wedbush from $57.00 to $65.00. They now have an "outperform" rating on the stock.
Beam Therapeutics Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Beam Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
Form 144 Beam Therapeutics Inc. Filed by: Ciaramella Giuseppe
Form S-8 Beam Therapeutics Inc.
Form 10-K Beam Therapeutics Inc. For: Dec 31
Form 8-K Beam Therapeutics Inc. For: Feb 24
Form 8-K Beam Therapeutics Inc. For: Feb 09
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.